6-year Follow-up Data After the Berberine Intervention Trial

Launched by SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Oct 4, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at the long-term effects of a natural supplement called berberine (BBR) on patients who have had colorectal adenomas, which are growths in the colon that can potentially lead to colorectal cancer. The original study showed that taking berberine for two years helped reduce the chances of these growths coming back after they were removed. Now, researchers want to see if berberine continues to provide protection from recurrence even after patients stop taking it, by following up with participants for six years after the previous study.

To be eligible for this follow-up study, participants must have completed the earlier berberine study. There are no specific exclusions, so most patients who participated in the first study can join. Those who take part can expect to be monitored for the recurrence of their colorectal adenomas over the next six years. This study is important because it aims to determine the long-term benefits of berberine in preventing colorectal cancer, ultimately helping improve patient care and outcomes.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: participants who completed the previous berberine intervention study (NCT02226185) Exclusion Criteria: no